Toggle Offcanvas
...
 
Melatonin Tenders

Melatonin Tenders

View Melatonin tenders, RFPs and contracts. Bid on readily available Melatonin tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Melatonin tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Melatonin.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Melatonin market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Melatonin tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

19 Live Notices for Melatonin Tenders

Showing 1 to 19

Object: Electronic Auction - Manipulated Medicines (Alpha -Lipoic Acid, Folic Acid, Calcium Carbonate And Others)
country Brazil
posting date03 Sep 2025
deadline18 Sep 2025
Object: Electronic Auction - Price Registration For Purchase (Art. 6, X Of Law No. 14,133, Of April 1, 2021) Of Medicines Ii, For Installment Supply, To Meet The Demands Of The Municipal Health Secretariat, Exclusively For The Participation Of Microcepress Me, Small Epp Or Equivalent Companies, Observing The Maximum Deadlines For Supply, The Technical Specifications And Minimum Performance And Quality Parameters In The Terms And Conditions Of The Notice.
country Brazil
posting date28 Aug 2025
deadline11 Sep 2025
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Active Ingredient Melatonin (Exclusively 1Mg And 5Mg), Atc N05Ch01 For The Period 01.08.2025 - 31.2012027
country Germany
posting date16 Jun 2025
deadline05 Jun 2027
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Active Ingredient Melatonin (Exclusively 1Mg And 5Mg), Atc N05Ch01 For The Period 01.08.2025 - 31.2012027
country Germany
posting date16 Jun 2025
deadline05 Jun 2027
Completion Of Non-Exclusive Discount Agreements According To Section 130A (8) Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So-Called Open House Process.
country Germany
posting date13 May 2025
deadline31 Dec 2026
Completion Of Non-Exclusive Discount Agreements According To §130A (8) Sgb V On Various Active Ingredient/En/Combinations With Any Final Option Within The Framework Of The So-Called Open House Procedure
country Germany
posting date25 Feb 2025
deadline05 Mar 2027
Pharmaceutical Discount Agreements From February 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date12 Dec 2024
deadline02 Dec 2026
Open House Drug Discount Agreements Melatonin, Excluding Dosage Form 2 Mg Sustained-Release Tablets, Atc N05Ch01
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Open House Drug Discount Agreements Melatonin, Excluding Dosage Form 2 Mg Sustained-Release Tablets, Atc N05Ch01
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Melatonin (N05Ch01), Excluding Prolonged-Release Tablets With An Effective Strength Of 2Mg As Part Of A So-Called Open-House Model.
country Germany
posting date17 Apr 2024
deadline31 Mar 2026
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Melatonin (N05Ch01), Excluding Prolonged-Release Tablets With An Effective Strength Of 2Mg As Part Of A So-Called Open-House Model.
country Germany
posting date16 Apr 2024
deadline31 Mar 2026
Degree Non-Excl. Drug Discount Ver. According To § 130A Paragraph 8 Sgb V Iwe So-Called Open-House Model For Ws Melatonin (Atc Code Who N05Ch01), Restricted To The Potency/Dosage 2Mg Prolonged-Release Tablet.
country Germany
posting date18 Jul 2023
deadline31 Oct 2025
Degree Non-Excl. Drug Discount Ver. According To § 130A Paragraph 8 Sgb V Iwe So-Called Open-House Model For Ws Melatonin (Atc Code Who N05Ch01), Restricted To The Potency/Dosage 2Mg Prolonged-Release Tablet.
country Germany
posting date18 Jul 2023
deadline31 Oct 2025
Degree Non-Excl. Drug Discount Ver. According To § 130A Paragraph 8 Sgb V Iwe So-Called Open-House Model For Ws Melatonin (Atc Code Who N05Ch01), Restricted To The Potency/Dosage 2Mg Prolonged-Release Tablet.
country Germany
posting date17 Jul 2023
deadline31 Oct 2025
Mebeverine Hcl 135Mg Tab,Tab Levosulpiride 75 Mg,Medroxy Progesterone 10 Mg Tab,Tab Melatonin 3 Mg, Quantity: 1603256
country India
posting date03 Sep 2025
deadline23 Sep 2025
Cap. Clomiphene Citrate+ Melatonin
country India
posting date01 Sep 2025
deadline11 Sep 2025
Spray Melatonin 0.3Mg Per Spray
country India
posting date30 Aug 2025
deadline17 Sep 2025
Tab/Cap. Melatonin 3 Mg
country India
posting date27 Aug 2025
deadline15 Sep 2025
Melatonin 3 Mg Tablet
country India
posting date22 Aug 2025
deadline10 Sep 2025

Share Share this page